Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Yeh

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
The Journal of Biological Chemistry|December 26, 2021
The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductaseLisa N Heppler, Sanaz Attarha, Rosanne Persaud, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 22, 2024
Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literatureChristopher Iriarte, Jennifer E Yeh, Allireza Alloo, et al.
American Journal of Hematology|December 29, 2020
Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analysesJennifer R Brown, Sarah R Walker, Lisa N Heppler, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
The Journal of Biological Chemistry|December 26, 2021
The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductaseLisa N Heppler, Sanaz Attarha, Rosanne Persaud, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 22, 2024
Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literatureChristopher Iriarte, Jennifer E Yeh, Allireza Alloo, et al.
American Journal of Hematology|December 29, 2020
Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analysesJennifer R Brown, Sarah R Walker, Lisa N Heppler, et al.
Pageof 9